Evidence map›Paper›PMID 28215946›Full record

Observational studyAmerican journal of kidney diseases : the official journal of the National Kidney Foundation2017

Reliability and Utility of the Surprise Question in CKD Stages 4 to 5.

Andrei D Javier, Rocio Figueroa, Edward D Siew, Huzaifah Salat, Jennifer Morse, Thomas G Stewart, Rakesh Malhotra, Manisha Jhamb, Jane O Schell, Cesar Y Cardona and 3 more

Abstract readMulticenter StudyObservational Study
In one paragraph

Observational study in American journal of kidney diseases : the official journal of the National Kidney Foundation, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 2 pooled it
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 2 syntheses or guidelines pooled it, 54 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. External validation of a prognostic model in routine practice for short- and long-term survival in peritoneal dialysis.Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis · 2026
    Article
  4. Article
  5. Population Health Management for Improving Kidney Health Outcomes.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2025
    Article
  6. Article
  7. Dialysis in the Elderly: A Practical Guide for the Clinician.International journal of nephrology · 2025
    Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Observational
  15. Article
  16. Serious Illness Treatment Preferences for Older Adults with Advanced CKD.Journal of the American Society of Nephrology : JASN · 2019
    Article
  17. Article
  18. The Surprise Question as a Prognostic Tool #360.Journal of palliative medicine · 2018
    Article
  19. Review
  20. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 1 country.

Andrei D JavierDivision of Nephrology and Hypertension, Vanderbilt University Medical Center, Nashville, TN; Vanderbilt Center for Kidney Disease, Nashville, TN.
Rocio FigueroaDivision of Nephrology, University of New Mexico, Albuquerque, NM.
Edward D SiewDivision of Nephrology and Hypertension, Vanderbilt University Medical Center, Nashville, TN; Vanderbilt Center for Kidney Disease, Nashville, TN.
Huzaifah SalatDivision of Nephrology and Hypertension, Vanderbilt University Medical Center, Nashville, TN; Vanderbilt Center for Kidney Disease, Nashville, TN.
Jennifer MorseDepartment of Biostatistics, Vanderbilt University, Nashville, TN.
Thomas G StewartDepartment of Biostatistics, Vanderbilt University, Nashville, TN.
Rakesh MalhotraDivision of Nephrology, University of California at San Diego, San Diego, CA.
Manisha JhambRenal-Electrolyte Division, University of Pittsburgh School of Medicine, Pittsburgh, PA.
Jane O SchellRenal-Electrolyte Division, University of Pittsburgh School of Medicine, Pittsburgh, PA; Section of Palliative Care and Medical Ethics, University of Pittsburgh School of Medicine, Pittsburgh, PA.
Cesar Y CardonaDivision of Nephrology, Meharry Medical College, Nashville, TN.
Cathy A MaxwellThe School of Nursing, Vanderbilt University, Nashville, TN.
T Alp IkizlerDivision of Nephrology and Hypertension, Vanderbilt University Medical Center, Nashville, TN; Vanderbilt Center for Kidney Disease, Nashville, TN.
Khaled Abdel-KaderDivision of Nephrology and Hypertension, Vanderbilt University Medical Center, Nashville, TN; Vanderbilt Center for Kidney Disease, Nashville, TN. Electronic address: khaled.abdel-kader@vanderbilt.edu.
Vanderbilt University · USVanderbilt University Medical Center · USUniversity of Pittsburgh · USMeharry Medical College · USUniversity of California, San Diego · USUniversity of New Mexico · US

Funding

The Vanderbilt Institute for Clinical and Translational Research (VICTR)UL1TR000445 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BERNARD, GORDON RAPHAEL · 2012 to 2016
$41.4M
Nutrition and Metabolism in Dialysis PatientsK24DK062849 · NIDDK · VANDERBILT UNIVERSITY · PI IKIZLER, TALAT ALP · 2003 to 2012
$1.6M
Developing, Validating, and Implementing a CKD Predictive Model (DELVECKD)K23DK090304 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI ABDEL-KADER, KHALED A · 2011 to 2015
$861k
NCATS NIH HHS UL1 TR000445NIDDK NIH HHS K23 DK090304NIDDK NIH HHS K24 DK062849
6 · The paper itself

Abstract

backgroundPrognostic uncertainty is one barrier to engaging in goals-of-care discussions in chronic kidney disease (CKD). The surprise question ("Would you be surprised if this patient died in the next 12 months?") is a tool to assist in prognostication. However, it has not been studied in non-dialysis-dependent CKD and its reliability is unknown. STUDY

designObservational study. SETTING &

participants388 patients at least 60 years of age with non-dialysis-dependent CKD stages 4 to 5 who were seen at an outpatient nephrology clinic. PREDICTOR: Trinary (ie, Yes, Neutral, or No) and binary (Yes or No) surprise question response. OUTCOMES: Mortality, test-retest reliability, and blinded inter-rater reliability. MEASUREMENTS: Baseline comorbid conditions, Charlson Comorbidity Index, cause of CKD, and baseline laboratory values (ie, serum creatinine/estimated glomerular filtration rate, serum albumin, and hemoglobin).

resultsMedian patient age was 71 years with median follow-up of 1.4 years, during which time 52 (13%) patients died. Using the trinary surprise question, providers responded Yes, Neutral, and No for 202 (52%), 80 (21%), and 106 (27%) patients, respectively. About 5%, 15%, and 27% of Yes, Neutral, and No patients died, respectively (P<0.001). Trinary surprise question inter-rater reliability was 0.58 (95% CI, 0.42-0.72), and test-retest reliability was 0.63 (95% CI, 0.54-0.72). The trinary surprise question No response had sensitivity and specificity of 55% and 76%, respectively (95% CIs, 38%-71% and 71%-80%, respectively). The binary surprise question had sensitivity of 66% (95% CI, 49%-80%; P=0.3 vs trinary), but lower specificity of 68% (95% CI, 63%-73%; P=0.02 vs trinary). LIMITATIONS: Single center, small number of deaths.

conclusionsThe surprise question associates with mortality in CKD stages 4 to 5 and demonstrates moderate to good reliability. Future studies should examine how best to deploy the surprise question to facilitate advance care planning in advanced non-dialysis-dependent CKD.

Indexed as

AgedAged, 80 and overFemaleHumansMaleMiddle AgedPrognosisProspective StudiesRenal Insufficiency, ChronicReproducibility of ResultsSeverity of Illness IndexSurveys and Questionnairesadvanced CKDadvance planningChronic kidney disease (CKD)clinical predictionclinical trajectoryend-of-life preferencesgeriatricgoals-of-care discussionsmortalitymortality risk predictionnephrology providernon–dialysis-dependent CKDprognosticationreliabilitysubjective health measuresurvival

Identifiers

PMID28215946
PMCPMC5771496
OpenAlexW2588351255

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.